Continuous leakage measurement during hyperthermic isolated limb perfusion

Annals of Surgical Oncology

Volumn 8, Issue 7, 2001, Pages 566-572

  Daryanani, D ^a   Komdeur, R ^a   Ter Veen, J ^a   Nijhuis, P H ^a   Piers, D A ^a   Hoekstra, H J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

131I albumin; HILP; Leakage monitoring; Melanoma; Sarcoma; Tumor necrosis factor

Indexed keywords

ALBUMIN I 131; MELPHALAN; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; FEMALE; HUMAN; ISOTOPE LABELING; LIMB PERFUSION; LIMB TUMOR; MAJOR CLINICAL STUDY; MALE; MELANOMA; PATIENT MONITORING; RADIOISOTOPE DISTRIBUTION; SOFT TISSUE SARCOMA;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; EXTREMITIES; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MALE; MELANOMA; MELPHALAN; MIDDLE AGED; RETROSPECTIVE STUDIES; SARCOMA; SEX FACTORS; SKIN NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034910696     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10434-001-0566-7     Document Type: Article

References (27)

1. Chemotherapy of cancer: Regional perfusion utilizing an extra-corporeal circuit
2. Selective heat sensitivity of cancer cells. Biochemical and clinical studies
3. Action of P-di(2-chloroethyl)-amino-L-phenylalanine on Harding Passey mouse melanoma
4. Regional perfusion treatment with melphalan for melanoma in a limb: An evaluation of drug kinetics
5. Systemic leakage during isolated limb perfusion for melanoma
6. Pharmacokinetics of melphalan in clinical isolation perfusion of the extremities
7. Continuous leakage monitoring during hyperthermic isolated regional perfusion of the lower limb: Techniques and results
8. Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience
9. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma
10. Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion
11. Evidence for the involvement of endothelial cell integrin alpha Vbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma
12. Combined cytotoxic effects of tumor necrosis factor-alpha with various cytotoxic agents in tumor cell lines that are drug resistant due to mutated p53
13. Cytokine levels and systemic toxicity in patients undergoing isolated limb perfusion with high-dose tumor necrosis factor, interferon gamma, and melphalan
14. Shock and tissue injury induced by recombinant human cachectin
15. Isolated regional perfusion in malignant melanoma of the extremities
16. Blood leakage and melphalan leakage from the perfusion circuit during regional hyperthermic perfusion for malignant melanoma
17. Rapid measurement of blood leakage during regional chemotherapy
18. Continuous monitoring of leakage during regional perfusion
19. The use of a hand-held gamma detector improves the safety of isolated limb perfusion
20. Leakage measurement during selective limb perfusion using a gamma probe
21. Improved tissue perfusion during pressure regulated hyperthermic regional isolated perfusion. A clinical study
22. Optimization of the vascular isolation in isolated regional perfusion of the limbs
23. Limb salvage by isolated limb perfusion (ILP) with TNF and melphalan in patients with locally advanced soft tissue sarcomas: Outcome of 270 ILPs in 246 patients
24. Systemic toxicity and cytokine/acute phase protein levels in patients after isolated limb perfusion with tumor necrosis factor-alpha complicated by high leakage
25. Systemic leakage and side effects of tumor necrosis factor alpha administered via isolated limb perfusion can be manipulated by flow rate adjustment
26. Systemic leakage and side effects of tumor necrosis factor alpha administration via isolated limb perfusion can be manipulated by flow rate adjustment